Outcomes of transoral robotic surgery: A preliminary clinical experience

Otolaryngology - Head and Neck Surgery

Volumn 145, Issue 2, 2011, Pages 248-253

  Hurtuk, Agnes ^a,b   Agrawal, Amit ^a,b   Old, Matthew ^a,b   Teknos, Theodoros N ^a,b   Ozer, Enver ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Head and neck squamous cell cancer; Transoral robotic surgery

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; EAR NOSE THROAT SURGERY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; LACERATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PEROPERATIVE COMPLICATION; PHARYNX HEMORRHAGE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; ROBOTICS; SQUAMOUS CELL CARCINOMA; STOMACH TUBE; TONSILLECTOMY; TRANSORAL ROBOTIC SURGERY; TREATMENT OUTCOME; COMPARATIVE STUDY; ENDOSCOPY; METHODOLOGY; MIDDLE AGED; MOUTH; OROPHARYNX TUMOR; PATHOLOGY; PILOT STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PILOT PROJECTS; PROSPECTIVE STUDIES; ROBOTICS; TREATMENT OUTCOME;

EID: 84856405578     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811402172     Document Type: Article

References (20)

1. Moore EJ, Henstorm DK, Olsen KD, et al. Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope. 2009; 119:508-515.
2. Weinstein GS, O'Malley BW Jr, Snyder W, et al. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007;133:1220-1226. (Pubitemid 350294250)
3. Ozer E, Waltonen J. Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions. Laryngoscope. 2008;118:1613-1616.
4. Weinstein GS, O'Malley BW, Snyder W, et al. Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol. 2007;116:19-23. (Pubitemid 46174121)
5. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119:2156-2164.
6. O'Malley BW, Weinstein GS, Snyder W, et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006;116:1465-1472. (Pubitemid 44181466)
7. Weinstein GS, Quon H, O'Malley BW, et al. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope. 2010;120:1749-1755.
8. Holsinger FC, Sweeney AD, Jantharapattana K, et al. The emergence of endoscopic head and neck surgery. Curr Oncol Rep. 2010;12:216-222.
9. Henstrom DK, Moore EJ, Olsen KD, Kasperbauer JL, McGree ME. Transoral resection for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg. 2009;135:1231-1238.
10. University of Pennsylvania School of Medicine. FDA clears TransOral robotic surgery. Science Daily, January 6, 2010. http://www.sciencedaily.com/ releases/2010/01/100104114553.htm. Accessed October 7, 2010.
11. Genden EM, Desai S, Sung CK. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2008;31:283-289.
12. Iseli TA, Kulbersh BD, Iseli CE, et al. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2009;141:166-171.
13. Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 2004;15:383-388. (Pubitemid 38444540)
14. Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin N Am. 2008;22:1125-1142.
15. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28:8-14.
16. Gillison ML, Koch WM, Capone RB, et al. Evidence for a casual association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720. (Pubitemid 30365531)
17. Fakhry C, Westra WH, Cmelak A, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269. (Pubitemid 351480538)
18. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-3589.
19. Shiley SG, Hargunani CA, Skoner JM, et al. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg. 2006;134:455-459. (Pubitemid 43267247)
20. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28:8-14.